Tiago Ferreira holds a Bachelor of Science in Genetics and Biotechnology and a Master of Science in Biotechnology for Health Sciences, both from the University of Trás-os-Montes and Alto Douro (UTAD). His master’s research project, entitled “Therapeutic effect of parecoxib: An in vivo study in Mus musculus,” was conducted at the Genotoxicity Laboratory and Animal Facility at UTAD. In 2019, he was awarded a research scholarship within the IBERPHENOL project (0377_IBERPHENOL_6_E) at UTAD, where he investigated the effects of natural compounds using animal models. Supported by an FCT scholarship, Tiago completed his PhD in Veterinary Sciences (Biomedical Sciences field) in 2025. His doctoral research was carried out at CITAB (UTAD), CICECO (University of Aveiro), and CI-IPOP (IPO), focusing on histopathological approaches, microRNA profiling, and 3D models applied to canine mammary tumors. Tiago is the author or co-author of 35 peer-reviewed scientific articles, 11 as first author, with his work cited in more than 270 academic publications (h-index = 11). He has contributed to over 70 scientific posters, leading 18 as first author, and has delivered 27 oral presentations, including three as first author. His research achievements have been recognized with 10 scientific awards. In addition, he has co-supervised both master’s and bachelor’s students, and has served as a peer reviewer for several international indexed journals.